1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

---

The cyclin-dependent kinase (CDK) 4/6 inhibitors Show prominent action in the management of Different types of Breast cancer. After the success of CDK 4/6 inhibitors in Breast cancer, a group of researchers is now examining the effect of...

Read More

---

CDK 4/6 Inhibitors May Cause Severe Lung Inflammation

Release Date: 27 September 2019

According to the safety announcement warning of FDA, the entire class of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors used to treat advanced metastatic breast cancers in some patients, may cause rare but severe inflammation of the lu...

Read More

---

Ribociclib-Fulvestrant Combinational Therapy Can Enhance Optimum Survival

Release Date: 27 September 2019

Current Study conducted in Barcelona, Spain suggested that addition of ribociclib to fulvestrant provides a synergistic action and significantly extended Overall Survival (OS) among postmenopausal women with hormone receptor-positive, HE...

Read More

---

Abrocitinib – Pfizer’s JAK Inhibitor Successfully Clears the Crucial Eczema Study

Release Date: 27 September 2019

Abrocitinib, an experimental drug of Pfizer shows positive late stage effects against Eczema. This drug belongs to category of drugs called Janus kinase inhibitors (JAK Inhibitors), which have some safety concerns. The family of JAK enzy...

Read More

---

CYC065 Successfully Treat an Advanced Solid Tumor Patient in Phase 1 Trial

Release Date: 27 September 2019

A biopharmaceutical company named Cyclacel Pharmaceuticals, recently announced treatment of the first patient with an oral formulation of CYC065. This drug is a CDK2/9 inhibitor, which is able to disturb the cell cycle of the cancerous c...

Read More

---

Second Generation CAR-T Cell Therapy Shows Prominent Action Against Leukemia and Lymphoma

Release Date: 27 September 2019

Recently, the researchers of US have developed a promising new CAR T-cell therapy of second generation that prevents the relapsing of lymphoma and leukemia and results in the 100% long term survival. It can target the BAFF-R protein, whi...

Read More

---

New Novel Drug Delivery Method using Pinpoint Targeting

Release Date: 26 September 2019

The action of most of the pharmaceutical depends upon the rapidity by which the drug reaches the target site. Most of them are ingested of injected into the body for achieving the desired action. Researchers are now working to develop mo...

Read More

---

Treatment of Chronic Diseases is Possible with Remote Control Implant

Release Date: 26 September 2019

A new Nano channel delivery system (nDS) is developed by the Researchers of Houston Methodist, which is able to deliver the medicament in a continuous and predetermined manner. The delivery can be controlled by remote control using a rem...

Read More

---

Synthetic Biologic System – A New Approach of Drug Delivery

Release Date: 26 September 2019

Researchers formulate a synthetic biologic system for the delivery of drug, which consist of some compartments like real cells. This project was performed especially for the Army at University of Massachusetts Amherst. It is also able to...

Read More

---

Cancer Drug Deliver using Nanogenerator

Release Date: 26 September 2019

Researchers of China recently develop a new drug delivery method known as Nanogenerator. It is an implantable device that can be used to establish a more accurate drug delivery system for cancer therapy. The device is very small with a l...

Read More

---

TG6002 Next generation Oncolytic Virus get Approval for Clinical Trails

Release Date: 26 September 2019

A new virus based immunotherapy was design and developed by a biotech company, for the treatment of solid tumors.  They got approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for phase I/IIa clinical tri...

Read More

---

Drug Delivery can be Achieved using Swimming Microbots

Release Date: 26 September 2019

Microbots, which are able to swim and deliver the drug, have developed by Swiss scientists. They are tiny sliver of elastic material, which swims along inside a narrow tube. They are able to coiling up and changing shape in response to t...

Read More

---

Laser Guided Microbots shows Prominent Action in Destroying Tumor Cells

Release Date: 26 September 2019

Some of the diseases or illness is difficult to treat and the medicine is not able to treat the illness. So, researchers at Caltech have implemented another method to control the incurable diseases. They use lasers to guide microbots ins...

Read More

---

Drug Targeting KRAS Mutation can Acts Against Lung Cancer Treatment

Release Date: 26 September 2019

The cases of lung cancer are increasing day by day. Lung cancer is the second most common cancer found in both men and women. It is estimated there will be roughly 228,000 new lung cancer cases this year. It is observed that nearly 30% o...

Read More

---

Setmelanotide Successfully Clears Phase 3 Of Clinical Trial

Release Date: 25 September 2019

Setmelanotide is a peptide drug, which is product of Rhythm pharmaceuticals. They developed this drug to reduce the weight gain and hunger in genetic obesity disorders. This drug has hit the goals of two late-stage clinical trials, and t...

Read More

---

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |